In this study we optimised the concentration of benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside (benzyl-α-GalNAc), a reagent used to inhibit the synthesis of mucin O-glycosylation of cellular models of human pancreatic cancer. Here, MUC5AC is linked to pancreatic neoplasm.